Clinical and immunologic features of the phenotype of systemic lupus erythematosus combined with Sjögren's syndrome

The problem of clinical and immunological heterogeneity of systemic lupus erythematosus (SLE) is of great interest, especially the combination of SLE and Sjögren's syndrome (SjS) determines a more favorable prognosis and specifics of therapy.Objective: to characterize the clinical and immunolog...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Современная ревматология
المؤلفون الرئيسيون:	S. K. Solovyev, E. A. Aseeva, A. A. Baranov, A. M. Lila, N. Yu. Nikishina, S. I. Glukhova
التنسيق:	مقال
اللغة:	الروسية
منشور في:	IMA-PRESS LLC 2023-08-01
الموضوعات:	combination of systemic lupus erythematosus and sjögren<sup>,</sup>s syndrome clinical and immunological features
الوصول للمادة أونلاين:	https://mrj.ima-press.net/mrj/article/view/1459

مواد مشابهة

Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus
حسب: E. A. Aseeva, وآخرون
منشور في: (2022-12-01)

Clinical and immunological phenotypes of systemic lupus erythematosus, identified based on cluster analysis of data from 400 patients from V.A. Nasonova Research Institute of Rheumatology
حسب: E. A. Aseeva, وآخرون
منشور في: (2022-10-01)

Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
حسب: A. A. Mesnyankina, وآخرون
منشور في: (2020-11-01)

Sjögren's disease and systemic lupus erythematosus overlap: immunological insights and therapeutic implications
حسب: Giovanni Fulvio, وآخرون
منشور في: (2025-09-01)

Features of B cell subsets in primary Sjogren’s syndrome and systemic lupus erythematosus
حسب: S. S. Benevolenskaya, وآخرون
منشور في: (2024-11-01)

Long-term results of therapy with sequential use of rituximab and belimumab in patients with systemic lupus erythematosus
حسب: S. K. Solovyev, وآخرون
منشور في: (2023-10-01)

Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus
حسب: N. Yu. Nikishina, وآخرون
منشور في: (2025-06-01)

Can number of platelets, blood red cell distribution, volume of neutrophil/lymphocyte ratio and mean platelet volume in patients with systemic lupus erythematosus and sjogren be used as an inflammation marker?
حسب: Arif Gulkesen, وآخرون
منشور في: (2019-03-01)

Treatment of patients with systemic lupus erythematosus without glucocorticoids – myth or reality?
حسب: S. K. Soloviev, وآخرون
منشور في: (2022-02-01)

Forecasting index of unfavorable outcomes of systemic lupus erythematosus
حسب: E. A. Aseeva, وآخرون
منشور في: (2021-06-01)

Rheumatic Diseases Presenting with Guillain-Barré Syndrome: Sjögren’s Syndrome and Systemic Lupus Erythematosus
حسب: Ebru Aytekin, وآخرون
منشور في: (2020-11-01)

Main circulating CD8<sup>+</sup> T cell subsets in patients with systemic lupus erythematosus
حسب: S. S. Benevolenskaya, وآخرون
منشور في: (2024-03-01)

Lupus nephritis – modern aspects of diagnosis and therapy. Part I
حسب: S. K. Solovyev, وآخرون
منشور في: (2024-03-01)

Cytotoxic Molecules as Potential Biomarkers for Active and Inactive Systemic Lupus Erythematosus
حسب: Paola Santana-Sánchez, وآخرون
منشور في: (2025-06-01)

Impact of Sjögren’s disease and its immunological characteristics on reaching remission or low disease activity state in systemic lupus erythematosus patients: a propensity score-matched longitudinal study
حسب: Haoze Zhang, وآخرون
منشور في: (2025-09-01)

Alterations of the fecal and vaginal microbiomes in patients with systemic lupus erythematosus and their associations with immunological profiles
حسب: Zongxin Ling, وآخرون
منشور في: (2023-03-01)

In Vitro Lupus Erythematosus Cells in Bone Marrow Aspirate: An Unexpected Clue in Systemic Lupus Erythematosus Presenting as Pancytopenia—A Case Report
حسب: Majed Abdul Basit Momin, وآخرون
منشور في: (2025-09-01)

Rhupus – a combination of systemic lupus erythematosus and rheumatoid arthritis as a separate disease phenotype (a clinical case)
حسب: N. Yu. Nikishina, وآخرون
منشور في: (2023-04-01)

The interconnected roles of TRIM21/Ro52 in systemic lupus erythematosus, primary Sjögren’s syndrome, cancers, and cancer metabolism
حسب: Chueh-Hsuan Hsu, وآخرون
منشور في: (2023-11-01)

Psoriasis and connective tissue diseases: What about Sjogren syndrome?
حسب: Zohra Aydi, وآخرون
منشور في: (2015-07-01)

Case Report: Siblings with neonatal lupus erythematosus
حسب: Pengyue Tang, وآخرون
منشور في: (2025-03-01)

Systemic lupus erythematosus: new horizons for diagnosis and therapy
حسب: S. K. Solovyev, وآخرون
منشور في: (2020-02-01)

Efficacy and safety of the type I interferon receptor inhibitor anifrolumab in patients with systemic lupus erythematosus (results of a 6-month study)
حسب: T. M. Reshetnyak, وآخرون
منشور في: (2024-04-01)

Demographic, Clinical and Immunological Manifestations of Systemic Lupus Erythematosus among Omani Population Single Tertiary Care Experience
حسب: Samata Al Dowaiki, وآخرون
منشور في: (2018-12-01)

The problem of fatigue in patients with systemic lupus erythematosus according to the data on a Russian RENAISSANCE cohort
حسب: E. A. Aseeva, وآخرون
منشور في: (2020-11-01)

A comparative cross-sectional study of psychological distress, fatigue, and physical activity in patients with rheumatoid arthritis, systemic lupus erythematosus, and Sjögren's disease
حسب: Sonja Beider, وآخرون
منشور في: (2025-01-01)

Clinical and laboratory relationships in patients with different variants of the course of systemic lupus erythematosus
حسب: V. A. Lila
منشور في: (2020-03-01)

Possibilities and prospects for glucocorticoid withdrawal in systemic lupus erythematosus
حسب: S. K. Solovyev, وآخرون
منشور في: (2020-03-01)

Management of patients with systemic lupus erythematosus in real clinical practice
حسب: E. A. Aseeva, وآخرون
منشور في: (2019-05-01)

THE REGISTRY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS, A EURASIAN COHORT (RENAISSANCE)
حسب: E. A. Aseeva, وآخرون
منشور في: (2016-12-01)

SELECTION OF AN OPTIMAL HEALTH-RELATED QUALITY-OF-LIFE QUESTIONNAIRE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
حسب: L. D. Vorobyeva, وآخرون
منشور في: (2018-11-01)

Long-term belimumab therapy in patients with systemic lupus erythematosus
حسب: A. A. Mesnyankina, وآخرون
منشور في: (2024-08-01)

Prospects for anti-BLyS treatment of systemic lupus erythematosus
حسب: S. K. Solovyov, وآخرون
منشور في: (2019-06-01)

Cutaneous lupus erythematosus: An update
حسب: Carina M Grönhagen, وآخرون
منشور في: (2014-01-01)

Kikuchi-Fujimoto Disease Preceding Overlap Syndrome of Sjögren’s Syndrome and Systemic Lupus Erythematosus: Literature Review Based on a Case Report
حسب: Cindy Cindy, وآخرون
منشور في: (2024-07-01)

Kikuchi-Fujimoto Disease Preceding Overlap Syndrome of Sjögren’s Syndrome and Systemic Lupus Erythematosus: Literature Review Based on a Case Report
حسب: Cindy Cindy, وآخرون
منشور في: (2024-04-01)

Tuberculosis in patients with systemic lupus erythematosus
حسب: Jomkwan Ongarj, وآخرون
منشور في: (2025-09-01)

THE EFFICIENCY OF BIOLOGICAL THERAPY AND THE FEATURES OF HUMORAL IMMUNITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
حسب: A. A. Mesnyankina, وآخرون
منشور في: (2018-07-01)

Portrait of a patient with systemic lupus erythematosus for the prescription of the type I interferon inhibitor anifrolumab
حسب: T. M. Reshetnyak, وآخرون
منشور في: (2023-12-01)

Characteristics of systemic lupus erythematosus in patients of Asian ethnicity
حسب: G. M. Koilubaeva, وآخرون
منشور في: (2025-02-01)